Serial entrepreneur and investor, Jesse John Francis Clark, founded HemoAware Corporation in October 2018. Clark was born with severe Hemophilia A and has always been active in the community. Clark was the Secretary of the board for the Nevada Chapter of The National Hemophilia Foundation. Clark resigned on that board after seeing the balance sheet of the chapter and the nominal amounts going back to community members. Jesse John Francis Clark founded HemoAware to expose the truth of the scam that these organizations have along with the pharma companies that are in their back pocket. Clark was the only community member to advocate the safety of Genentech’s Emicizumab (Hemlibra) which currently has 44 fatalities and that number keeps growing every quarter.
While Clark was at the helm of HemoAware, he created successful programs for the community which includes HemoFlights and HemoAware's Financial Assistance program. Clark is known for being the first patient to be kicked out of a Hemophilia Treatment Center.
Jesse John Francis Clark resigned as President and CEO of HemoAware Corporation in January 2020 to launch Fixx Pharmaceuticals, a biotechnology company in pursuit of curing hemophilia through gene editing.
HemoAware is now in the hands of a very passionate and dedicated board.